Drotaverine Hydrochloride

盐酸屈他维林

Report date: 2023/04/21 17:24:38
NME

Base Information

Drug NameDrotaverine Hydrochloride
Drug Alias Name氢喹维林DrotaverinaDrotaverinum氢乙罂粟碱屈他维林 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsMuscle Spasticity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChinoin Pharmaceutical And Chemical Works Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChinoin Pharmaceutical And Chemical Works Co Ltd
Inactive CompaniesN/A
Active IndicationsMuscle Spasticity
Inactive IndicationsN/A

Other Information

ATC CodeA03AD02
Related LinksWikipediaDrugBankKEGG